The National Congress on the Future of Pharmaceuticals in Medical Care 2000
  Overview | Agenda | Sponsors | Privacy Policy | Contact Us | Past Congress Home | Main Home 
         
 

Agenda Overview

Day 1

Day 2

Day 3

Agenda : Day Three

Friday, November 17, 2000


Presentation materials, where available, are in .pdf format and require that you have Adobe Acrobat Reader installed on your computer. If you do not have this plug-in, please visit the Adobe site and download it.


7:00 a.m.

Continental Breakfast

8:00 a.m. Pharmaceutical Research, Development and Manufacturing — The State of the Industry
  Raymond Gilmartin, Chairman, President and CEO, Merck & Co., Inc., Whitehouse Station, NJ
No Presentation Materials

8:45 a.m. Pharmaceutical Benefit Managers — The State of The Industry
  Barrett A. Toan, President and CEO, Express Scripts, Inc., Maryland Heights, MO
Presentation Material


9:30 a.m. The Biotechnology Enterprise — The State of the Industry
Edward Penhoet, Ph.D., Dean, School of Public Health, University of California at Berkeley, and Former CEO, Chiron, Berkeley, CA
Presentation Material


10:15 a.m. The Role of Health Insurers and Health Plans
Dean Rosen, Esq., Senior Vice President of Policy and General Counsel, Health Insurance Association of America, Washington, D.C.
Presentation Material


11:00 a.m. Break

11:15 a.m. The Role of Silicon Valley and Wall Street in the Finance and Structure of the New Science and Technology
 

Geoffrey E. Harris, C.F.A., Managing Director, Health Care Services Equity Research, UBS Warburg Dillon & Read, New York, NY
Presentation Material


NOON
Lunch and Presentations

12:30 p.m. Spending More on Pharmaceuticals: Good News, Bad News or the Wrong Question?
  Robert DuBois, M.D. Ph.D. CEO, Protocare Sciences, Santa Monica, CA
Presentation Material


1:15 p.m. Purchasers, Health Plans and Providers: Managing Pharmaceutical Quality and Costs

David Lorber, M.D., Assistant Vice President, PCS Health Systems, Inc., Scottsdale, AZ

  Craig S. Stern, Pharm.D. M.B.A., President, Pro Pharma Pharmaceutical Consultants, Northridge, CA
 

Nicholas Vasilopoulos, Principal, William M. Mercer, Inc., New York, NY

Richard E. Dixon, M.D., F.A.C.P. (Moderator)
No Presentation Materials


2:15 p.m. Regulating the Pharmaceutical Enterprise
  Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD
Presentation Material


3:00 p.m.

Break

3:15 p.m.

Science and Technology Policy Alternatives for the New Administration and Congress

Judy Feder, Ph. D., Dean of Policy Studies, Georgetown University, Georgetown Public Policy Institute, Washington, D.C.

Gail Wilensky, Ph.D., Chair, The Medicare Payment Advisory Commission, Bethesda, MD

John K. Iglehart, Founding Editor, Health Affairs, Project Hope, Washington, D.C. (Moderator)
No Presentation Materials

4:30 p.m.

Adjournment

 

Back to Top

 
Overview | Agenda | Sponsors | Privacy Policy | Contact Us | Past Congress Home | Main Home